mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.05 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.05 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.06 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |